Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality - PubMed (original) (raw)

doi: 10.1038/ki.2014.275. Epub 2014 Jul 30.

Maria Larkina 2, David A Goodkin 2, Yun Li 3, Ronald L Pisoni 2, Brian Bieber 2, Nancy Mason 4, Lin Tong 2, Francesco Locatelli 5, Mark R Marshall 6, Masaaki Inaba 7, Bruce M Robinson 3

Affiliations

• PMID: 25075769
• DOI: 10.1038/ki.2014.275

Free article

Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality

George R Bailie et al. Kidney Int. 2015 Jan.

Free article

Abstract

Intravenous (IV) iron is required for optimal management of anemia in the majority of hemodialysis (HD) patients. While IV iron prescription has increased over time, the best dosing strategy is unknown and any effect of IV iron on survival is unclear. Here we used adjusted Cox regression to analyze associations between IV iron dose and clinical outcomes in 32,435 HD patients in 12 countries from 2002 to 2011 in the Dialysis Outcomes and Practice Patterns Study. The primary exposure was total prescribed IV iron dose over the first 4 months in the study, expressed as an average dose/month. Compared with 100-199 mg/month (the most common dose range), case-mix-adjusted mortality was similar for the 0, 1-99, and 200-299 mg/month categories but significantly higher for the 300-399 mg/month (HR of 1.13, 95% CI of 1.00-1.27) and 400 mg/month or more (HR of 1.18, 95% CI of 1.07-1.30) groups. Convergent validity was proved by an instrumental variable analysis, using HD facility as the instrument, and by an analysis expressing IV iron dose/kg body weight. Associations with cause-specific mortality (cardiovascular, infectious, and other) were generally similar to those for all-cause mortality. The hospitalization risk was elevated among patients receiving 300 mg/month or more compared with 100-199 mg/month (HR of 1.12, 95% CI of 1.07-1.18). In light of these associations, a well-powered clinical trial to evaluate the safety of different IV iron-dosing strategies in HD patients is urgently needed.

PubMed Disclaimer

Comment in

• Intravenous iron administration: new observations and time for the next steps.
  Weiss G, Kronenberg F. Weiss G, et al. Kidney Int. 2015 Jan;87(1):10-2. doi: 10.1038/ki.2014.324. Kidney Int. 2015. PMID: 25549119

Similar articles

• Evaluating the effectiveness of IV iron dosing for anemia management in common clinical practice: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
  Robinson BM, Larkina M, Bieber B, Kleophas W, Li Y, Locatelli F, McCullough KP, Nolen JG, Port FK, Pisoni RL. Robinson BM, et al. BMC Nephrol. 2017 Nov 9;18(1):330. doi: 10.1186/s12882-017-0745-9. BMC Nephrol. 2017. PMID: 29121874 Free PMC article.
• Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
  Bailie GR, Larkina M, Goodkin DA, Li Y, Pisoni RL, Bieber B, Mason N, Tong L, Locatelli F, Marshall MR, Inaba M, Robinson BM. Bailie GR, et al. Nephrol Dial Transplant. 2013 Oct;28(10):2570-9. doi: 10.1093/ndt/gft062. Nephrol Dial Transplant. 2013. PMID: 24078642
• Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
  Charytan C, Bernardo MV, Koch TA, Butcher A, Morris D, Bregman DB. Charytan C, et al. Nephrol Dial Transplant. 2013 Apr;28(4):953-64. doi: 10.1093/ndt/gfs528. Epub 2012 Dec 5. Nephrol Dial Transplant. 2013. PMID: 23222534 Clinical Trial.
• The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
  Qunibi WY. Qunibi WY. Arzneimittelforschung. 2010;60(6a):399-412. doi: 10.1055/s-0031-1296304. Arzneimittelforschung. 2010. PMID: 20648931 Review.
• The safety of intravenous iron preparations: systematic review and meta-analysis.
  Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. Avni T, et al. Mayo Clin Proc. 2015 Jan;90(1):12-23. doi: 10.1016/j.mayocp.2014.10.007. Epub 2014 Oct 30. Mayo Clin Proc. 2015. PMID: 25572192 Review.

Cited by

• High ferritin is associated with liver and bone marrow iron accumulation: Effects of 1-year deferoxamine treatment in hemodialysis-associated iron overload.
  Nunes LLA, Dos Reis LM, Osorio R, Guapyassú HKA, Moysés RMA, Leão Filho H, Elias RM, Rochitte CE, Jorgetti V, Custodio MR. Nunes LLA, et al. PLoS One. 2024 Aug 9;19(8):e0306255. doi: 10.1371/journal.pone.0306255. eCollection 2024. PLoS One. 2024. PMID: 39121099 Free PMC article.
• Iron deficiency and supplementation in heart failure.
  Lakhal-Littleton S, Cleland JGF. Lakhal-Littleton S, et al. Nat Rev Cardiol. 2024 Jul;21(7):463-486. doi: 10.1038/s41569-024-00988-1. Epub 2024 Feb 7. Nat Rev Cardiol. 2024. PMID: 38326440 Review.
• Safety and Efficacy of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors vs. Erythropoietin-Stimulating Agents in Treating Anemia in Renal Patients (With or Without Dialysis): A Meta-Analysis and Systematic Review.
  Damarlapally N, Thimmappa V, Irfan H, Sikandari M, Madhu K, Desai A, Pavani P, Zakir S, Gupta M, Khosa MM, Kotak S, Varrassi G, Khatri M, Kumar S. Damarlapally N, et al. Cureus. 2023 Oct 21;15(10):e47430. doi: 10.7759/cureus.47430. eCollection 2023 Oct. Cureus. 2023. PMID: 38021836 Free PMC article. Review.
• Association of Estimated Total Body Iron with All-Cause Mortality in Japanese Hemodialysis Patients: The Miyazaki Dialysis Cohort Study.
  Toida T, Sato Y, Komatsu H, Fujimoto S. Toida T, et al. Nutrients. 2023 Nov 3;15(21):4658. doi: 10.3390/nu15214658. Nutrients. 2023. PMID: 37960311 Free PMC article.
• Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study.
  Asmar J, Chelala D, El Hajj Chehade R, Azar H, Finianos S, Aoun M. Asmar J, et al. PLoS One. 2023 Jan 31;18(1):e0280871. doi: 10.1371/journal.pone.0280871. eCollection 2023. PLoS One. 2023. PMID: 36719878 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • H1 Connect

• Medical

  • MedlinePlus Health Information